Ra Pharmaceuticals, Inc. i-capital capital
Ra Pharmaceuticals, Inc. capitalization kwi-intanethi namhlanje kwiidola. Ra Pharmaceuticals, Inc. ingxowankulu ulwazi oluvulekileyo. Olu lwazi lolwazi malunga Ra Pharmaceuticals, Inc. capitalization. Ra Pharmaceuticals, Inc., i-capitalisation - 2 271 550 464 iidola zaseMelika.
Ra Pharmaceuticals, Inc. ivolumu yezorhwebo
Namhlanje, Ra Pharmaceuticals, Inc. kwenzeke kwiimarike ezahlukeneyo zesitokhwe. Itshathi yemihla ngemihla yokurhweba ye Ra Pharmaceuticals, Inc. ikwiwebhusayithi yethu. Ra Pharmaceuticals, Inc. kubanjwe kuthengiso oluninzi lwesitoko ngexesha langempela, sibonisa umthamo wokuthengisa wemihla ngemihla Ra Pharmaceuticals, Inc.. Ixabiso layo yonke i Ra Pharmaceuticals, Inc. izitokhwe ezikhutshiweyo (Ra Pharmaceuticals, Inc. cap cap) yehle nge $ -709 888.
|
Ra Pharmaceuticals, Inc. istatshi yekhredithi yemakethe
Ra Pharmaceuticals, Inc. capitalisation kwigrafu ngeminyaka. Utshintsho ngaphakathi Ra Pharmaceuticals, Inc. capitalise ngenyanga ngu 0%. 0% - Ra Pharmaceuticals, Inc. utshintsho lwemalike lonyaka. Ra Pharmaceuticals, Inc. i-capitalisation inciphile xa kuthelekiswa nezolo.
| Iveki | Inyanga | iinyanga 3 | Unyaka | Iminyaka emithathu |
Ra Pharmaceuticals, Inc. imbali yenkxaso-mali
| Umhla |
Ixabiso
Imali-mali (intengo-mali yemarike) yixabiso lemarike yazo zonke izabelo zeenkampani ezithengiswa kwi-stock exchange. Imali yentengo yemali ilingana nexabiso lezabelo ezandisiwe ngenani lezabelo ezikhoyo.
|
|---|---|
| 01/04/2020 | 2 271 550 464 $ |
| 31/03/2020 | 2 272 260 352 $ |
| 30/03/2020 | 2 236 290 560 $ |
| 27/03/2020 | 2 223 985 152 $ |
| 26/03/2020 | 2 246 229 504 $ |
| 25/03/2020 | 2 250 962 432 $ |
| 24/03/2020 | 2 167 426 816 $ |
Ra Pharmaceuticals, Inc. isatifiketi somqulu
| Iveki | Inyanga | iinyanga 3 | Unyaka | Iminyaka emithathu |
Ra Pharmaceuticals, Inc. idatha yembali yevolumu
| Umhla |
Umqulu (24h)
Ixabiso lezorhwebo leRa Pharmaceuticals, Inc. izabelo yintlawulo yenani lazo zonke iintengiso kunye neengxenye ze-RARX ezithengiweyo kwaye zathengiswa ngexesha lomhla okhethiweyo.
|
|---|---|
| 01/04/2020 | 3 864 670 $ |
| 31/03/2020 | 6 856 718 $ |
| 30/03/2020 | 861 523 $ |
| 27/03/2020 | 1 079 895 $ |
| 26/03/2020 | 272 965 $ |
| 25/03/2020 | 5 428 001 $ |
| 24/03/2020 | 826 178 $ |
Iimali yentengiso enkulu ye Ra Pharmaceuticals, Inc. kwiidola zaseMelika ngoku 01/04/2020. Ra Pharmaceuticals, Inc. i-capitalisation yentengiso kwi 31/03/2020 ilingana ne 2 272 260 352 iidola zaseMelika. Ra Pharmaceuticals, Inc. capitalization e 30/03/2020 ifikelele kuthi 2 236 290 560 iidola zaseMelika. Vuliwe 27/03/2020, Ra Pharmaceuticals, Inc. capitalisation yayiyi- $ 2 223 985 152.
Ra Pharmaceuticals, Inc. capitalization ilingane 2 246 229 504 Iidola zaseMelika ku- 26/03/2020. Ra Pharmaceuticals, Inc. capitalisation yimali eyi- $ 2 250 962 432 kwi 25/03/2020. Vuliwe 24/03/2020, Ra Pharmaceuticals, Inc. capitalisation yayiyi- $ 2 167 426 816.
Inkcitho ye-Ra Pharmaceuticals, Inc. namhlanje ngu-2 271 550 464 $. Iimali zentengiso ye-Ra Pharmaceuticals, Inc. ishintshile -0.0312% xa kuthelekiswa nezolo. Imali yokuthengisa ye RARX izabelo ze Ra Pharmaceuticals, Inc. ngosuku lokugqibela lokurhweba lilinganiselwa kuma-3 864 670 $. Ixabiso lokuthengiswa kwezabelo ze Ra Pharmaceuticals, Inc. latshintshile kwi--43.637% xa kuthelekiswa nosuku lwangaphambili lworhwebo.